ribociclib
novartis
['breast', ' ribo', 'natalee', 'lcsm,(-blcsm)']
natalee results yesterday at #asco2023 ! ribo now the second calka/6 to show reduction in risk of recurrence in patients with hormone receptor positive breast cancer. this further strengthens use of colk4/6i in the early stage setting. #lcsm 
MD @harvard ,MSc medical Oncology, #breastcancer & Researcher American Board Certified.Member of the European Society of Oncology. 𝒞ℴ𝒻𝒻ℯℯ ☕︎♥︎